[go: up one dir, main page]

Fabian et al., 1987 - Google Patents

Induction of morphological and functional differentiation of human myeloid leukemia cells (HL-60 and LK) by a benzoic acid derivative of retinoic acid

Fabian et al., 1987

Document ID
410374765194025470
Author
Fabian I
Shvartzmayer S
Fibach E
Publication year
Publication venue
Leukemia research

External Links

Snippet

In previous studies we have shown that the synthetic retinoid (E)-4 [2–5, 6, 7, 8-tetrahydro-5, 5, 8, 8-tetramethyl-2-naphthalenyl-1-propenylbenzoic acid (TTNPB) stimulates the growth of myeloid progenitors from normal and myelodysplastic patients. In the present study we …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells

Similar Documents

Publication Publication Date Title
Honma et al. Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids
Miyaura et al. 1α, 25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells
Meyskens Jr et al. Characterization of the effects of different retinoids on the growth and differentiation of a human melanoma cell line and selected subclones
Breitman et al. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.
Ferrero et al. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation
Sidell Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro
Grossfeld et al. Action of hydrocortisone on cells in tissue culture.
Bruce et al. Longitudinal study of in vivo wound repair and in vitro cellular senescence of dermal fibroblasts
Asou et al. Resveratrol, a natural product derived from grapes, is a new inducer of differentiation in human myeloid leukemias
Priestley et al. Hyperactivity of fibroblasts cultured from psoriatic skin: I. Faster proliferation and effect of serum withdrawal
Kalemkerian et al. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer
Asou et al. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines
Patrick Burns et al. Effect of docosahexaenoic acid on rate of differentiation of HL-60 human leukemia
Chang et al. Dose-dependent effects of a tumor promotor on blast cell progenitors in human myeloblastic leukemia
Keles et al. Nerve growth factor receptor expression in medulloblastomas and the potential role of nerve growth factor as a differentiating agent in medulloblastoma cell lines
Schroder et al. Growth inhibitory and stimulatory effects of retinoic acid on murine 3T3 cells.
Fabian et al. Induction of morphological and functional differentiation of human myeloid leukemia cells (HL-60 and LK) by a benzoic acid derivative of retinoic acid
Gamba-Vitalo et al. Differentiation of WEHI-3B D+ monomyelocytic leukemia cells by retinoic acid and aclacinomycin A
Ochiai et al. Role of JAK2 signal transductional pathway in activation and survival of human peripheral eosinophils by interferon‐gamma (IFN‐γ)
Akeo et al. Superoxide dismutase activity and growth of retinal pigment epithelial cells are suppressed by 20% oxygen in vitro
HARPER et al. Vitamin A potentiates the mitogenic effect of epidermal growth factor in cultures of normal adult human skin fibroblasts
Gargus et al. Rapid changes in bidirectional K+ fluxes preceding DMSO‐induced granulocytic differentiation of HL‐60 human leukemic cells
Sanford et al. Retinoid protection against x-ray-induced chromatid damage in human peripheral blood lymphocytes.
Steinberg et al. Loss of suppression of normal bone marrow colony formation by leukemic cell lines after differentiation is induced by chemical agents
Koeffler et al. The effect of retinoids on haemopoiesis—clinical and laboratory studies